// STATE LEGISLATION TRACKER

Oklahoma SB 724: Physician Advisory Committee; removing authority to establish parameters for certain maintenance or treatment. Effective

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Oklahoma
Bill: SB 724
Filed: 2021-02-01
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Oklahoma SB 724 appears to address the state Physician Advisory Committee tied to workers' compensation medical treatment guidelines, not peptide prescribing or compounding. Based on the title, subjects, and bill history available, it does not appear to change access to compounded peptides, telehealth peptide care, NP/naturopath scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No apparent change to compounded peptide access
No apparent change to off-label prescribing rules
No apparent change to telehealth prescribing
No apparent NP or naturopath scope change
Looks focused on workers' compensation treatment guidelines

What to Watch For

Note This bill seems procedural and workers' compensation-focused, not peptide-specific.

Note If reused in a later session, check whether amended text adds prescribing or compounding language.

Where the Bill Stands

The 2021 record shows Senate passage and House committee action, but no final passage or enactment is shown before the session ended.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws